The store will not work correctly when cookies are disabled.
N-(3-Aminoethyl)[3-(4-Fluorophenyl)(1H-Indazol-5-yl)]Carboxamide
ID: ALA3983999
PubChem CID: 20789099
Max Phase: Preclinical
Molecular Formula: C16H15FN4O
Molecular Weight: 298.32
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: NCCNC(=O)c1ccc2[nH]nc(-c3ccc(F)cc3)c2c1
Standard InChI: InChI=1S/C16H15FN4O/c17-12-4-1-10(2-5-12)15-13-9-11(16(22)19-8-7-18)3-6-14(13)20-21-15/h1-6,9H,7-8,18H2,(H,19,22)(H,20,21)
Standard InChI Key: RVQRMCFFWQBUNF-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
16.1608 -2.1296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1597 -2.9491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8677 -3.3581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8659 -1.7208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5745 -2.1260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5793 -2.9446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3594 -3.1931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8367 -2.5279 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3516 -1.8686 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6151 -3.9642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0701 -4.5746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3266 -5.3497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1276 -5.5156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6718 -4.9002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4124 -4.1275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3857 -6.2909 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.4516 -3.3572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7442 -2.9480 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4510 -4.1744 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0362 -3.3561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3288 -2.9469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6208 -3.3550 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
7 10 1 0
13 16 1 0
2 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
20 21 1 0
21 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 298.32 | Molecular Weight (Monoisotopic): 298.1230 | AlogP: 2.06 | #Rotatable Bonds: 4 |
Polar Surface Area: 83.80 | Molecular Species: BASE | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.58 | CX Basic pKa: 9.16 | CX LogP: 1.75 | CX LogD: 0.00 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.69 | Np Likeness Score: -1.51 |
References
1. (2002) Indazole derivatives as JNK inhibitors and compositions and methods related thereto, |